How to Get Lumizyme (Alglucosidase Alfa) Covered by Humana in New York: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Lumizyme Covered by Humana in New York

Humana requires prior authorization for Lumizyme (alglucosidase alfa) for Pompe disease treatment. To get coverage in New York: (1) Submit Humana's PA form with confirmed Pompe diagnosis (enzyme deficiency + genetic testing), (2) Include medical necessity documentation showing prior therapy failures or contraindications, (3) If denied, file internal appeal within 65 days, then external appeal through New York DFS within 4 months. Start today: Call Humana at the number on your member ID card to request PA forms, or log into your MyHumana portal to check formulary status and submit electronically.

Table of Contents

  1. Understanding Your Humana Coverage
  2. Reading Your Denial Letter
  3. Fixing Common Coverage Issues
  4. Filing Your First Appeal
  5. Peer-to-Peer Review Strategy
  6. New York External Appeals Process
  7. Medical Necessity Documentation
  8. Appeal Templates and Scripts
  9. Tracking Your Case
  10. Cost Assistance Options
  11. When All Else Fails

Understanding Your Humana Coverage

Humana Medicare Advantage and Part D plans require prior authorization for Lumizyme (HCPCS code J2778), used to treat Pompe disease. This expensive enzyme replacement therapy—approximately $993 per 50-mg vial according to Sanofi's WAC disclosure—faces rigorous utilization management.

Coverage Requirements at a Glance

Requirement Details Where to Verify Source
Prior Authorization Required for all plans Humana PA medication list Humana 2025 PA List
Medical Necessity Confirmed Pompe diagnosis + failed alternatives Plan Evidence of Coverage Member portal
Step Therapy May apply (marked with †) Part B preferred drug list Humana 2025 ST List
Formulary Status Check plan-specific list MyHumana drug search Member portal
Tip: Log into MyHumana or call the number on your member ID card to verify your specific plan's requirements before starting treatment.

Reading Your Denial Letter

When Humana denies Lumizyme coverage, the denial letter contains crucial information for your appeal. Look for these key elements:

Reason Codes to Watch For:

  • Medical necessity not established: Insufficient documentation of Pompe diagnosis
  • Step therapy required: Must try preferred alternatives first
  • Non-formulary: Drug not on your plan's covered list
  • Quantity limits exceeded: Requesting more than plan allows

Critical Deadlines:

  • Internal appeal: 65 days from denial notice
  • External appeal (New York): 4 months from final internal denial
  • Expedited appeals: Available if delay jeopardizes health

Fixing Common Coverage Issues

Before filing a formal appeal, check if your denial stems from fixable administrative issues:

Missing Documentation

Problem: Humana didn't receive complete Pompe diagnosis confirmation Solution: Submit enzyme deficiency test results (GAA activity <40% of normal) plus genetic confirmation showing two disease-causing GAA gene variants

Coding Issues

Problem: Wrong HCPCS code or missing NDC number Solution: Ensure your provider uses correct J2778 code and includes specific NDC for the 50-mg vial formulation

Prescriber Requirements

Problem: Non-specialist prescriber Solution: Obtain prescription from or consultation with a metabolic specialist, neurologist, or physician experienced in Pompe disease management

From our advocates: We've seen cases where simply resubmitting with complete genetic testing results and a specialist consultation note resolved denials that initially seemed complex. The key is thorough documentation from the start.

Filing Your First Appeal

Step-by-Step Internal Appeal Process

  1. Gather Required Documents (Patient/Caregiver)
    • Original denial letter
    • Complete medical records
    • Enzyme and genetic test results
    • Provider's medical necessity letter
    • Timeline: Immediate
  2. Complete Humana Appeal Form (Patient or Provider)
  3. Submit Supporting Evidence (Provider)
    • Medical necessity letter addressing denial reason
    • Prior therapy documentation
    • Clinical guidelines supporting Lumizyme use
    • Timeline: With appeal form
  4. Track Your Submission (Patient)
    • Fax to 1-877-486-2621 or submit via provider portal
    • Request confirmation receipt
    • Timeline: Same day as submission
  5. Await Decision (Humana)
    • Standard: 30 days for Part C, 7 days for Part D
    • Expedited: 72 hours if health at risk
    • Timeline: Per CMS requirements

Peer-to-Peer Review Strategy

If your initial appeal is denied, request a peer-to-peer review before proceeding to external appeals. This allows your prescriber to speak directly with Humana's medical director.

Preparation Checklist for Your Provider:

  • Clinical Summary: Concise patient history, symptoms, functional decline
  • Prior Treatments: Specific therapies tried, doses, durations, outcomes
  • Contraindications: Why alternatives are inappropriate
  • Guidelines: FDA labeling, specialty society recommendations
  • Outcomes Data: Expected benefits, monitoring plan

Scheduling: Call Humana provider services to request peer-to-peer within 7 days of denial.

New York External Appeals Process

New York residents have strong appeal rights through the Department of Financial Services (DFS). After exhausting Humana's internal process, you can request an independent external review.

External Appeal Timeline

Step Deadline Decision Time Next Action
File external appeal 4 months from final internal denial 30 days standard, 72 hours expedited DFS assigns independent reviewer
Submit additional docs As requested by reviewer N/A Respond promptly to avoid delays
Receive decision N/A Binding on Humana If approved, coverage required

Required Forms and Submission

Submit your external appeal through the DFS Portal with these documents:

  • New York State External Appeal Application
  • Comprehensive Physician Attestation Form (signed)
  • All medical records and test results
  • Humana's final denial letter
  • Supporting medical literature
Note: For expedited review (24-hour decision for drug denials), your physician must attest that delay seriously jeopardizes your life or health.

Free Help Available

Community Health Advocates provides free assistance with New York insurance appeals. Call 888-614-5400 (Monday-Friday, 9am-4pm) for help filing your external appeal or navigating the process.

Medical Necessity Documentation

Your provider's medical necessity letter is crucial for Lumizyme approval. It should address:

Required Clinical Elements:

  • Confirmed Diagnosis: Pompe disease with enzyme deficiency and genetic confirmation
  • Disease Impact: Respiratory function decline, muscle weakness, functional limitations
  • Treatment History: Prior therapies attempted, reasons for failure or intolerance
  • Lumizyme Rationale: Why this specific ERT is medically necessary
  • Monitoring Plan: How response will be assessed and safety monitored

Supporting Evidence to Include:

  • Enzyme activity test results (GAA deficiency)
  • Genetic testing showing two pathogenic GAA variants
  • Pulmonary function tests showing decline
  • Muscle strength assessments
  • Prior medication trial documentation

Counterforce Health specializes in crafting evidence-backed appeals for complex specialty medications like Lumizyme, helping patients and providers navigate payer-specific requirements and build compelling medical necessity cases.

Appeal Templates and Scripts

Patient Phone Script for Humana

"Hi, I'm calling about a prior authorization denial for Lumizyme for my Pompe disease. My member ID is [ID number]. I'd like to file an internal appeal and request the appeal forms. Can you also tell me the specific reason for denial and the deadline for my appeal? I'll need this information faxed to my doctor's office at [fax number]."

Medical Necessity Letter Framework

Opening: "I am writing to appeal the denial of Lumizyme (alglucosidase alfa) for [patient name] who has confirmed Pompe disease."

Clinical Justification:

  • Diagnosis confirmation with test results
  • Current symptoms and functional decline
  • Prior treatment failures with specific details
  • Why Lumizyme is medically necessary
  • Expected outcomes and monitoring plan

Closing: "Based on the clinical evidence and established guidelines, Lumizyme is medically necessary for this patient. I request immediate approval."

Tracking Your Case

Appeal Tracking Log

Date Action Taken Humana Contact Follow-up Due Status
PA submitted
Denial received
Internal appeal filed
Peer-to-peer completed
External appeal filed

Key Phone Numbers:

  • Humana Member Services: Number on your ID card
  • Humana Provider Services: 1-800-457-4652
  • New York DFS Appeals: 1-800-400-8882
  • Community Health Advocates: 888-614-5400

Cost Assistance Options

While working through appeals, explore financial assistance:

Manufacturer Support

  • Sanofi Patient Connection: Income-based assistance program
  • Copay Support: May reduce out-of-pocket costs for eligible patients
  • Bridge Programs: Temporary supply during appeals process

Foundation Grants

  • National Organization for Rare Disorders (NORD): Patient assistance programs
  • Patient Advocate Foundation: Copay relief and case management
  • Muscular Dystrophy Association: May provide support for Pompe patients

When All Else Fails

If your Lumizyme appeal is ultimately denied:

Alternative Coverage Options:

  • Formulary Exception: Request coverage as non-formulary drug with higher copay
  • Alternative ERTs: Consider Nexviazyme (avalglucosidase) if formulary-covered
  • Clinical Trials: Explore research studies for access
  • State Programs: Check New York Medicaid or other state assistance

Regulatory Complaints:

  • File DFS Complaint: If Humana violates appeal timelines or procedures
  • Contact State Insurance Department: For broader coverage issues
  • Medicare Complaints: If Medicare Advantage plan violations

Frequently Asked Questions

Q: How long does Humana prior authorization take for Lumizyme in New York? A: Standard PA decisions within 72 hours for Part D drugs, 14 days for medical benefit. Expedited decisions within 24 hours if health at risk.

Q: What if Lumizyme isn't on my Humana formulary? A: Request a formulary exception with medical necessity documentation. Your provider must show why formulary alternatives are ineffective or cause adverse effects.

Q: Can I get expedited appeals for Lumizyme? A: Yes, if delay would seriously jeopardize your health. Your physician must provide written attestation for expedited internal and external appeals.

Q: Does New York require step therapy for Pompe disease treatments? A: Possibly. Check your specific plan's step therapy requirements, but medical necessity may override if other ERTs are contraindicated.

Q: What happens if I start Lumizyme while my appeal is pending? A: You'll be responsible for costs until approval. Consider manufacturer bridge programs or temporary financial assistance.

Sources & Further Reading


Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice or legal counsel. Always consult with your healthcare provider about treatment decisions and consider professional advocacy services for complex appeals. Coverage policies and procedures may change; verify current requirements with your specific plan and state regulators.

For personalized assistance with your Lumizyme appeal, Counterforce Health helps patients and providers navigate complex prior authorization and appeals processes with evidence-backed strategies tailored to specific payer requirements.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.